Target Name: Histamine Receptor (HR)
NCBI ID: P5847
Review Report on Histamine Receptor (HR) Target / Biomarker Content of Review Report on Histamine Receptor (HR) Target / Biomarker
Histamine Receptor (HR)
Other Name(s): None

HR Plays A Crucial Role in Immune System Regulation

Histamine Receptor (HR) is a protein that is expressed in various tissues throughout the body, including the skin, eyes, and mucous membranes. It plays a crucial role in the immune system, as it helps to regulate the release of histamine from mast cells and basophiles. Histamine is a well-known neuropeptide that is involved in various physiological processes, including inflammation, pain, and itching.

The HR protein is a member of the superfamily of G protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play a broad role in cellular signaling. GPCRs are characterized by the presence of a transmembrane domain, a catalytic domain, and an extracellular portion that contains a regulatory protein-interactive region.

HR is expressed in various tissues, including the skin, eyes, and mucous membranes, and is involved in the regulation of various physiological processes, including inflammation, pain, and itching. It is a potential drug target and may be useful in the treatment of various diseases.

One of the main functions of HR is its role in the regulation of histamine release from mast cells and basophils. Mast cells and basophils are specialized immune cells that play a crucial role in the immune response. They are capable of producing and releasing large amounts of histamine, which is involved in the regulation of various physiological processes, including inflammation, pain, and itching.

HR plays a critical role in the regulation of histamine release from these cells by interacting with the histamine receptor on the surface of these cells. The HR protein is known to interact with the Fc portion of the histamine receptor, which is a critical region of the receptor that is involved in the regulation of histamine release.

Additionally, HR is involved in the regulation of the activation and deactivation of mast cells and basophils. Mast cells and basophils are highly responsive to various stimuli, including allergens and irritants, and their activation is tightly regulated. HR plays a critical role in the regulation of this process by interacting with the exocytosis of these cells, which is the process by which these cells release their contents into the cytosol.

HR is also involved in the regulation of the inflammatory response. Mast cells and basophiles are a source of inflammatory mediators, including histamine, which is involved in the regulation of various physiological processes, including inflammation, pain, and itching. HR plays a critical role in the regulation of this process by interacting with the signaling pathways that regulate the activation and deactivation of these cells.

In addition to its role in the regulation of histamine release, HR is also involved in the regulation of various other physiological processes. For example, HR is involved in the regulation of the growth and differentiation of various cell types, including epithelial cells, and it is also involved in the regulation of the cytoskeleton structure and stability.

HR is a potential drug target, as its regulation of various physiological processes makes it an attractive target for the development of new treatments for various diseases. For example, HR may be a useful target for the treatment of allergies, as histamine release is a key component of allergic responses. Additionally, HR may be a potential target for the treatment of parasitic infestations, as it is involved in the regulation of the inflammatory response.

HR is also a potential biomarker, as its regulation of various physiological processes makes it an attractive target for the development of new diagnostic tests. For example, HR may be used as a biomarker for the diagnosis of neurodegenerative diseases, as its regulation of the inflammatory response is involved in the development of these conditions.

In conclusion, HR is a protein that is involved in various physiological processes throughout the body, including the regulation of histamine release from mast cells and basophiles. It plays a critical role in the immune system, as it helps to regulate the release of histamine from these cells. HR is a potential drug target and

Protein Name: Histamine Receptor (HR) (nonspecified Subtype)

The "Histamine Receptor (HR) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Histamine Receptor (HR) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Histocompatibility antigen-related | Histone | Histone acetyltransferase (HAT) | Histone deacetylase | Histone H2A | Histone H2B | Histone H3 | Histone Lysine Demethylase | Histone methyltransferase | HIVEP1 | HIVEP2 | HIVEP3 | HJURP | HJV | HK1 | HK2 | HK2P1 | HK3 | HKDC1 | HLA Class II Histocompatibility Antigen DM (HLA-DM) | HLA class II histocompatibility Antigen DO (HLA-DO) | HLA class II histocompatibility antigen DP (HLA-DP) | HLA Class II Histocompatibility Antigen DQ8 | HLA class II histocompatibility antigen DR (HLA-DR) | HLA Class II Histocompatibility Antigen, DQ (HLA-DQ) | HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 | HLA complex group 16 (non-protein coding), transcript variant X2 | HLA complex group 8 | HLA-A | HLA-B | HLA-C | HLA-DMA | HLA-DMB | HLA-DOA | HLA-DOB | HLA-DPA1 | HLA-DPA2 | HLA-DPA3 | HLA-DPB1 | HLA-DPB2 | HLA-DQA1 | HLA-DQA2 | HLA-DQB1 | HLA-DQB1-AS1 | HLA-DQB2 | HLA-DRA | HLA-DRB1 | HLA-DRB2 | HLA-DRB3 | HLA-DRB4 | HLA-DRB5 | HLA-DRB6 | HLA-DRB7 | HLA-DRB8 | HLA-DRB9 | HLA-E | HLA-F | HLA-F-AS1 | HLA-G | HLA-H | HLA-J | HLA-K | HLA-L | HLA-N | HLA-P | HLA-U | HLA-V | HLA-W | HLCS | HLF | HLTF | HLX | HM13 | HMBOX1 | HMBS | HMCES | HMCN1 | HMCN2 | HMG20A | HMG20B | HMGA1 | HMGA1P2 | HMGA1P4 | HMGA1P7 | HMGA1P8 | HMGA2 | HMGA2-AS1 | HMGB1 | HMGB1P1 | HMGB1P10 | HMGB1P19 | HMGB1P37 | HMGB1P38 | HMGB1P46 | HMGB1P5 | HMGB1P6 | HMGB2 | HMGB2P1 | HMGB3 | HMGB3P1